|
Delayed
Australian S.E.
03:21:13 09/11/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.3300 AUD | 0.00% |
|
-7.04% | -49.23% |
| Market Cap | 101M 69.32M 62.19M 56.85M 51.84M 97.89M 6.5B 685M 273M 3.48B 260M 254M 10.98B | P/E 2027 * |
-3.3x | P/E 2028 * | 17.4x |
|---|---|---|---|---|---|
| Enterprise Value | 129M 88.73M 79.61M 72.77M 66.37M 125M 8.32B 877M 349M 4.45B 333M 325M 14.06B | EV / Sales 2027 * |
17.9x | EV / Sales 2028 * | 4.68x |
| Free-Float |
62.76% | Yield 2027 * |
-
| Yield 2028 * | - |
Australian S.E.AUD
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| RCE | Delayed | |
Deutsche Boerse AG
| R9Q | Delayed | |
|
Börse Stuttgart
| R9Q | Delayed | |
|
Boerse Muenchen
| R9Q | Real-time | |
|
Tradegate
| R9Q | Real-time |
| 1 week | -7.04% | ||
| Current month | -8.33% | ||
| 1 month | +15.79% | ||
| 3 months | -14.29% | ||
| 6 months | -34.00% | ||
| Current year | -49.23% |
| 1 week | 0.32 |  | 0.36 |
| 1 month | 0.26 | | 0.36 |
| Current year | 0.26 | | 0.73 |
| 1 year | 0.26 | | 0.73 |
| 3 years | 0.26 | | 0.73 |
| 5 years | 0.26 | | 1.38 |
| 10 years | 0.13 | | 1.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
James Graham
CEO | Chief Executive Officer | - | 28/08/2020 |
Justin Reynolds
DFI | Director of Finance/CFO | - | - |
Michele Dilizia
CTO | Chief Tech/Sci/R&D Officer | - | 30/09/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Michele Dilizia
BRD | Director/Board Member | - | 01/10/2012 |
James Graham
BRD | Director/Board Member | - | 01/05/2012 |
| Director/Board Member | - | 01/09/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 31/07/26 | Buy | Chief Executive Officer | 25,000 | 0.0083% | ||
| 31/07/26 | Buy | Director | 75,000 | 0.0250% | ||
| 31/07/26 | Buy | Director | 37,500 | 0.0125% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -7.04% | -22.35% | -25.00% | 69.39M | |
| -0.79% | -4.48% | +46.48% | +125.69% | 1,206B | |
| +1.43% | +1.11% | +48.05% | +83.05% | 665B | |
| +1.07% | -1.21% | +32.92% | +104.92% | 515B | |
| -0.36% | -3.25% | +45.42% | +65.10% | 381B | |
| -0.14% | -1.87% | +70.06% | +41.09% | 362B | |
| -0.78% | -0.52% | +30.47% | +58.09% | 307B | |
| -0.80% | -0.21% | +7.98% | +36.17% | 289B | |
| +0.03% | -1.20% | +43.79% | +69.83% | 249B | |
| -0.41% | -2.22% | +40.43% | +107.03% | 207B | |
| Average | -0.08% | -2.22% | +34.33% | +66.60% | 417.98B | |
| Weighted average by Cap. | -0.04% | -1.96% | +42.71% | +88.11% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 7.2M 4.95M 4.44M 4.06M 3.7M 6.98M 464M 48.86M 19.48M 248M 18.54M 18.14M 784M | 24.6M 16.9M 15.16M 13.86M 12.64M 23.86M 1.58B 167M 66.54M 848M 63.34M 61.98M 2.68B |
| Net income | -29.4M -20.2M -18.12M -16.56M -15.1M -28.52M -1.89B -200M -79.52M -1.01B -75.69M -74.07M -3.2B | 6.1M 4.19M 3.76M 3.44M 3.13M 5.92M 393M 41.4M 16.5M 210M 15.71M 15.37M 664M |
| Net Debt | 28.26M 19.42M 17.42M 15.92M 14.52M 27.42M 1.82B 192M 76.45M 974M 72.77M 71.21M 3.08B | 14.2M 9.75M 8.75M 8M 7.3M 13.78M 915M 96.37M 38.41M 490M 36.56M 35.78M 1.55B |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/11/26 | A$0.3300 | 0.00% | 11,196 |
| 06/11/26 | A$0.3300 | 0.00% | 48,608 |
| 05/11/26 | A$0.3300 | -1.49% | 46,793 |
| 04/11/26 | A$0.3350 | 0.00% | 11,865 |
| 03/11/26 | A$0.3350 | -5.63% | 83,392 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- RCE Stock
Select your edition
All financial news and data tailored to specific country editions
